MedPath

AI-Powered DIY Screening System for Diabetic Retinopathy

Not Applicable
Recruiting
Conditions
Diabetic Retinopathy
Registration Number
NCT06892353
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

A pragmatic trial will be conducted in two representative clinics in each of the three types of targeted settings. It will be run for 3 months in each clinic to complete data collection of up to 100 patients in SPGC and Optometry Clinics, 200 at GPGC and 200 in GOPC in total. All the subjects will conduct a DIY screening, physician consultation, survey with questionnaires and a phone interview three months after their baseline assessment. This study will assess automated screening in terms of success rate of the DIY system without active assistant help, accuracy, screening rate and detection rate, adherence to referral and experience of participants, as well as cost-effectiveness in real-world settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  1. subjects who are 50 years of age or older, or subjects who are 18 years of age or older and have diabetes, and
  2. have not undertaken an eye examination in the previous 12 months (elevated risk of undiagnosed disease).
  3. Provide written informed consent.
Exclusion Criteria
  1. individuals with physical disabilities that prevent the use of a fundus camera, or
  2. individuals with speech impairments who are unable to complete telephone follow-ups.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Success Rate without Active Assistant Help3 months

Success rate of using the DIY screening booth help will be determined by the number of successful screening runs without active assistant help divided by the total number of screening runs.

Secondary Outcome Measures
NameTimeMethod
Assessment of Consumer Acceptability3 months

Assessment of consumer acceptability will be determined by the positive response rate/screening rate (i.e. the total number of eligible patients who agree to screening (numerator) divided by the total number of eligible individuals (denominator)).

Diagnostic Accuracy3 months

All retinal images will be re-graded by two independent ophthalmologists, with any disagreements adjudicated by a third ophthalmologist (gold standard). This grading result will be considered as gold standard reference for the diagnostic accuracy of the automated screening. The indicators for diagnostic accuracy include: area under curve.

Disease Detection Rates3 months

The detection rate is defined as the proportion of newly diagnosed DR cases divided by the total number of eligible individuals.

Adherence to Referral3 months

Patient adherence to referral will be measured as the proportion of patients who attend an ophthalmology service among the total number of referred patients.

Technical Feasibility: Quality of Image Acquisition3 months

The investigators will use a standardized checklist to assess the quality of images acquired during the study. This checklist will include criteria resolution, clarity, and completeness of the images. A sample of images will be reviewed by a panel of experts to ensure consistency and reliability in the assessment.

Cost-effectiveness of DIY Screening3 months

The cost-effective analyses will involve using the incremental cost-effectiveness ratio (ICER) as the key indicator to identify whether DIY screening model is a good investment.

Assessment of Consumer Satisfaction3 months

The responses to the 5-point Likert scale question will be analysed using the "document variable statistics" function in MAXQDA software. Data from the open-ended questionnaire will be analysed thematically. All themed information will be shared for review by project steering committee. The Likert scale ranges from 1 to 5. The content includes 5 options, including strongly disagree, disagree, neural, agree, strongly agree. The higher scores (e.g., 4 or 5) indicate a stronger agreement or a more positive attitude towards the statement, while lower scores (e.g., 1 or 2) indicate disagreement or a more negative attitude.

Technical Feasibility:The duration of Clinic Flow3 months

The investigators will conduct time-motion studies to evaluate the impact of the new imaging process on clinic flow. This will track the time taken for image acquisition, processing, and reporting and record the total time spent.

Technical Feasibility:Reporting and Impact on Clinic Flow3 months

The investigators will involve track any delays or disruptions in the clinic schedule.

Technical Feasibility: The type of technical error3 months

The investigators will maintain a log of technical errors encountered during the image acquisition process. This log will include the type of error.

Technical Feasibility: Number of Recorded Technical Errors3 months

The investigators will maintain a log of technical errors encountered during the image acquisition process. This log will record the frequency of each type of technical errors.

Technical Feasibility: Remedies for technical errors3 months

The investigators will maintain a log of technical errors encountered during the image acquisition process. This log will document any corrective actions taken in response to technical errors. Regular review meetings will be held to analyze these errors and implement strategies to minimize their occurrence.

Trial Locations

Locations (1)

SPGC and Optometry Clinics

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath